Skip to content
10-Q

Quarterly Report

NANOVIRICIDES, INC. NNVC

0001410578-24-000843

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · May 14, 2024 11.81M sh
Cash And Equivalents Q3 2024 · Mar 31, 2024 $3.26M
Cash And Equivalents Q3 2024 · Jun 30, 2023 $8.15M
Current Liabilities Q3 2024 · Mar 31, 2024 $813.34K
Current Liabilities Q3 2024 · Jun 30, 2023 $534.25K
Total Liabilities Q3 2024 · Mar 31, 2024 $813.34K
Total Liabilities Q3 2024 · Jun 30, 2023 $2.03M
Current Assets Q3 2024 · Mar 31, 2024 $3.52M
Current Assets Q3 2024 · Jun 30, 2023 $8.45M
Total Assets Q3 2024 · Mar 31, 2024 $11.46M
Total Assets Q3 2024 · Jun 30, 2023 $16.9M
Shares Diluted Q3 2024 · Mar 31, 2023 11.64M sh
Shares Diluted Q3 2024 · Mar 31, 2023 11.61M sh
Capex Q3 2024 · Mar 31, 2023 $149.15K
Operating Cash Flow Q3 2024 · Mar 31, 2023 −$4.17M
Stockholders Equity Q3 2024 · Mar 31, 2023 $18.23M
Stockholders Equity Q3 2024 · Dec 31, 2022 $19.87M
Stockholders Equity Q3 2024 · Sep 30, 2022 $21.56M
Stockholders Equity Q3 2024 · Jun 30, 2022 $23.08M
Eps Diluted Q3 2024 · Mar 31, 2023 −$0.15
Eps Diluted Q3 2024 · Mar 31, 2023 −$0.43
Eps Basic Q3 2024 · Mar 31, 2023 −$0.15
Eps Basic Q3 2024 · Mar 31, 2023 −$0.43
Sga Expense Q3 2024 · Mar 31, 2023 $614.65K
Sga Expense Q3 2024 · Mar 31, 2023 $1.79M
Rd Expense Q3 2024 · Mar 31, 2023 $1.2M
Rd Expense Q3 2024 · Mar 31, 2023 $3.48M
Net Income Q3 2024 · Mar 31, 2023 −$1.7M
Net Income Q3 2024 · Mar 31, 2023 −$5.02M
Net Income Q3 2024 · Dec 31, 2022 −$1.75M
Net Income Q3 2024 · Sep 30, 2022 −$1.57M
Operating Income Q3 2024 · Mar 31, 2023 −$1.81M
Operating Income Q3 2024 · Mar 31, 2023 −$5.27M